Early escape and survival mechanisms of HR + BC in response to ET involve adaptive upregulation of growth factor receptor tyrosine kinases (RTKs), which promotes ligand-independent activation of estrogen receptors (ER) through MAP kinase signaling and phosphorylation of Ser11 of ER5–7. This evidence concerns the gene ESR1 and breast cancer.